Prelude Therapeutics is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet need.
For more details on financing and valuation for Prelude Therapeutics, register or login.
By registering, you agree to Forge’s Terms of Use. Already registered? Log in
PRLD
6.4 as of 3/29/23
To read this article and more news on Prelude Therapeutics, register or login.
